These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3390998)

  • 21. Influence of uremia and hemodialysis on the plasma protein binding of tolmetin.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Pharmacology; 1984; 29(6):312-9. PubMed ID: 6505005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac.
    Smith PC; Hasegawa J; Langendijk PN; Benet LZ
    Drug Metab Dispos; 1985; 13(1):110-2. PubMed ID: 2858367
    [No Abstract]   [Full Text] [Related]  

  • 23. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
    Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
    Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and disposition of tolmetin in the horse.
    Van Eenoo P; Delbeke FT; Roels K; Baert K
    J Pharm Biomed Anal; 2003 Mar; 31(4):723-30. PubMed ID: 12644199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the metabolism of tolmetin to the chemically reactive acyl-coenzyme A thioester intermediate in rats.
    Olsen J; Li C; Skonberg C; Bjørnsdottir I; Sidenius U; Benet LZ; Hansen SH
    Drug Metab Dispos; 2007 May; 35(5):758-64. PubMed ID: 17303625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
    Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zomepirac kinetics in healthy males.
    Nayak RK; Ng KT; Gottlieb S; Plostnieks J
    Clin Pharmacol Ther; 1980 Mar; 27(3):395-401. PubMed ID: 7357796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of tolmetin kinetics in rheumatoid arthritis and matched healthy controls.
    Furst DE; Dromgoole SH; Fow S; Landaw EM
    J Clin Pharmacol; 1983; 23(11-12):557-62. PubMed ID: 6662979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
    Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
    Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry.
    Ding A; Zia-Amirhosseini P; McDonagh AF; Burlingame AL; Benet LZ
    Drug Metab Dispos; 1995 Mar; 23(3):369-76. PubMed ID: 7628303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a major metabolite on the plasma protein binding of tolmetin.
    Pritchard JF; Desiraju RK
    J Pharm Sci; 1982 Aug; 71(8):964-5. PubMed ID: 7120110
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies By tandem mass spectrometry.
    Qiu Y; Burlingame AL; Benet LZ
    Drug Metab Dispos; 1998 Mar; 26(3):246-56. PubMed ID: 9492388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
    Mroszczak EJ; Lee FW; Combs D; Sarnquist FH; Huang BL; Wu AT; Tokes LG; Maddox ML; Cho DK
    Drug Metab Dispos; 1987; 15(5):618-26. PubMed ID: 2891477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and metabolism of tolmetin in normal and adjuvant arthritic Lewis rats.
    Grindel JM; Migdalof BH; Yorgey KA; Pritchard JF
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):299-306. PubMed ID: 6984679
    [No Abstract]   [Full Text] [Related]  

  • 35. The time course of tolmetin and its metabolites in the plasma of individual rats and mice.
    Migdalof BH; Yorgey KA; Popkave CG
    Drug Metab Dispos; 1976; 4(5):468-73. PubMed ID: 10146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-pressure liquid chromatographic (HPLC) determination of tolmetin and its major metabolite in plasma.
    Ayres JW; Sakmar E; Hallmark MR; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):475-83. PubMed ID: 847299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteers.
    Furst DE; Dromgoole SH; Desiraju RK; Paulus HE
    J Clin Pharmacol; 1983 Jul; 23(7):329-35. PubMed ID: 6886031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein binding of tolmetin.
    Selley ML; Madsen BW; Thomas J
    Clin Pharmacol Ther; 1978 Dec; 24(6):694-705. PubMed ID: 710027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein.
    Volland C; Sun H; Dammeyer J; Benet LZ
    Drug Metab Dispos; 1991; 19(6):1080-6. PubMed ID: 1687014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the pharmacokinetics and metabolism of zomepirac in man and animals.
    Muschek LD; Grindel JM
    J Clin Pharmacol; 1980 Apr; 20(4):223-9. PubMed ID: 6769977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.